Cited by 405Ovarian function and disordersReproductive Biology and FertilitySexual Differentiation and Disorders

The DOI matches its Crossref record; 40 of the 42 references it cites were found in a registry or an index.

The Biochemical Basis for Increased Testosterone Production in Theca Cells Propagated from Patients with Polycystic Ovary Syndrome

Nelson, Velen L., Qin, Ke-nan, Rosenfield, Robert L., Wood, Jennifer R., Penning, Trevor M., Legro, Richard S., Strauss, Jerome F., McAllister, Jan M.·2001·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jcem.86.12.8088

Open this paper in CoChat — free account

Abstract

Ovarian theca cells propagated from patients with polycystic ovary syndrome (PCOS) convert steroid precursors into T more efficiently than normal theca cells. To identify the basis for increased T production by PCOS theca cells, we examined type I-V 17 beta-hydroxysteroid dehydrogenase (17 beta HSD) isoform expression in long-term cultures of theca and granulosa cells isolated from normal and PCOS ovaries. RT-PCR analysis demonstrated that theca cells express type V 17 beta HSD a member of the aldo-keto reductase (AKR) superfamily (17 beta HSDV, AKR1C3), whereas expression of type I, II, and IV 17 beta HSD, which are members of the short-chain dehydrogenase/reductase superfamily, was limited to granulosa cells. Type III 17 beta HSD, the testicular isoform, was not detected in either granulosa or theca cells. Northern and real-time PCR analyses demonstrated that 17 beta HSDV transcripts were not significantly increased in PCOS theca cells compared with normal theca cells. RT-PCR analysis revealed that theca cells also express another AKR, 20 alpha HSD (AKR1C1). Both basal and forskolin-stimulated 20 alpha HSD mRNA levels were increased in PCOS theca cells compared with normal theca cells. However, 17 beta HSD enzyme activity per theca cell was not significantly increased in PCOS, suggesting that neither AKR1C3 nor AKR1C1 contributes to the formation of T in this condition. In contrast, 17 alpha-hydroxylase/C17,20 lyase and 3 beta HSD enzyme activities were elevated in PCOS theca cells, driving increased production of T precursors. These findings indicate that 1) increased T production in PCOS theca cells does not result from dysregulation of "androgenic" 17 beta HSD activity or altered expression of AKRs that may express 17 beta HSD activity; and 2) increased synthesis of T precursors is the primary factor driving enhanced T secretion in PCOS.

Integrity signals

Registry

Crossref · 10.1210/jcem.86.12.8088

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary Syndrome
Nestler, J. E., & Jakubowicz, D. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350902 · Cited by 743
Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome
Legro, R. S., Driscoll, D., Strauss, J. F., Fox, J., & Dunaif, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14956 · Cited by 699
Self-citation
REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME
Yen, S. S. C. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb02132.x · Cited by 697
Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones
PENNING, T. M., BURCZYNSKI, M. E., JEZ, J. M., HUNG, C.-F., LIN, H.-K., MA, H., MOORE, M., PALACKAL, N., & RATNAM, K. (2000) · Biochemical Journal · doi:10.1042/bj3510067 · Cited by 649
Self-citation
Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3
Geissler, W. M., Davis, D. L., Wu, L., Bradshaw, K. D., Patel, S., Mendonca, B. B., Elliston, K. O., Wilson, J. D., Russell, D. W., & Andersson, S. (1994) · Nature Genetics · doi:10.1038/ng0594-34 · Cited by 570
The Ovarian Androgen Producing Cells: A Review of Structure/Function Relationships1,2
Erickson, G. F., Magoffin, D. A., Dyer, C. A., & Hofeditz, C. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-3-371 · Cited by 569
Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries
Nelson, V. L., Legro, R. S., Strauss, J. F., & McAllister, J. M. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.6.0311 · Cited by 556
Self-citation
Polycystic Ovary Syndrome as a Form of FunctionalOvarian Hyperandrogenism Due to Dysregulation ofAndrogen Secretion*
EHRMAN, D. A., Barnes, R. B., & Rosenfield, R. L. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-322 · Cited by 498
Self-citation
Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion
Ehrmann, D. A. (1995) · Endocrine Reviews · doi:10.1210/er.16.3.322 · Cited by 394
The Polycystic Ovary. I. Clinical and Histologic Features
Goldzieher, J. W., & Green, J. (1962) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-22-3-325 · Cited by 369

Flagged first, then by citations

Show all 42 references

2 of the 42 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

Zawadzki, 1992, Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach, In: Dunaif A, Givens JR, Haseltine FP, Merriam G, eds. Current issues in endocrinology and metabolism. Polycystic ovary syndrome. Boston: Blackwell;, 377
McAllister, 1993, Human theca interna cells in culture, In: Heindel J, Chapin R, eds. Methods in toxicology. San Diego: Academic Press;, 330

Sorted by citations

Items 201–300 of 405

Polycystic Ovary Syndrome
Zweig, S. B., Tolentino, M. C., & Poretsky, L. (2004) · Springer eBooks · doi:10.1007/978-1-4757-6260-0_38 · Cited by 19
Effect of Citrullus colocynthis hydro-alcoholic extract on hormonal and folliculogenesis process in estradiol valerate-induced PCOs rats model: An experimental study
Barzegar, M. H., Khazali, H., Khazali, H., & Kalantar, S. M. (2017) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.29252/ijrm.15.10.9 · Cited by 19
Bisphenol A and polycystic ovary syndrome in human: A systematic review
Urbanetz, L. A. M. L., Soares, J. M., Simões, R. S., Maciel, G. A. R., Baracat, M. C. P., & Baracat, E. C. (2024) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15349 · Cited by 18
Steroid Hormones and Other Lipid Molecules Involved in Human Reproduction
Strauss, J. F., & FitzGerald, G. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00004-4 · Cited by 21
Self-citation
Characterization of the basal promoter element of the human type 5 17beta-hydroxysteroid dehydrogenase gene
Qin, K., & Rosenfield, R. L. (2005) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2005.01.015 · Cited by 19
Self-citation
Chronic anovulation and the polycystic ovary syndrome
KASE, N. G. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003254.012 · Cited by 16
Reinke crystals: Hallmarks of adult Leydig cells in humans
Planinić, A., Marić, T., Bojanac, A. K., & Ježek, D. (2022) · Andrology · doi:10.1111/andr.13201 · Cited by 16
Angiotensin-(1-7), Angiotensin-Converting Enzyme 2 and Mas Receptor in Rat Polycystic Ovaries
Pereira, V. M., dos Reis, F. M., Casalechi, M., & dos Reis, A. M. (2020) · Protein and Peptide Letters · doi:10.2174/0929866527666200826104410 · Cited by 16
Key signalling pathways underlying the aetiology of polycystic ovary syndrome
Walters, K. A., Moreno-Asso, A., Stepto, N. K., Pankhurst, M. W., Paris, V. R., & Rodgers, R. J. (2022) · Journal of Endocrinology · doi:10.1530/joe-22-0059 · Cited by 19
Prepubertal estrogen exposure modifies neurotrophin receptor expression in celiac neurons and alters ovarian innervation
Anesetti, G., Lombide, P., & Chávez‐Genaro, R. (2008) · Autonomic Neuroscience · doi:10.1016/j.autneu.2008.10.021 · Cited by 16
Requirement for Proximal Putative Sp1 and AP-2 cis-Deoxyribonucleic Acid Elements in Mediating Basal and Luteinizing Hormone- and Insulin-Dependent in Vitro Transcriptional Activation of the CYP17 Gene in Porcine Theca Cells
Zhang, G., & Veldhuis, J. D. (2004) · Endocrinology · doi:10.1210/en.2003-1545 · Cited by 16
Absence of Polycystic Ovary Syndrome Features in Human Immunodeficiency Virus-Infected Women Despite Significant Hyperinsulinemia and Truncal Adiposity
Johnsen, S., Dolan, S. E., Fitch, K. V., Killilea, K. M., Shifren, J. L., & Grinspoon, S. K. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1083 · Cited by 16
Adolescent androgen abnormalities
Stafford, D. E. J., & Gordon, C. M. (2002) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/00001703-200210000-00002 · Cited by 16
Hydrohysteroid Dehydrogenases – Biological Role and Clinical Importance – Review
Atanassova, N. N., & Koev, Y. (2012) · InTech eBooks · doi:10.5772/54149 · Cited by 16
Adipose Tissue is a Potential Source of Hyperandrogenism in Obese Female Rats
Wagner, I. V., Sahlin, L., Savchuk, I., Klöting, N., Svechnikov, K., & Söder, O. (2018) · Obesity · doi:10.1002/oby.22198 · Cited by 15
Clinical and Metabolic Effects of Alpha-Lipoic Acid Associated with Two Different Doses of Myo-Inositol in Women with Polycystic Ovary Syndrome
Fruzzetti, F., Benelli, E., Fidecicchi, T., & Tonacchera, M. (2020) · International Journal of Endocrinology · doi:10.1155/2020/2901393 · Cited by 15
Study of RNA interference inhibiting rat ovarian androgen biosynthesis by depressing 17alpha-hydroxylase/17, 20-lyase activity in vivo
Li, Y., Liang, X., Wei, L., Xiong, Y.-L., Yang, X., Shi, H.-G., & Yang, Z.-H. (2009) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-7-73 · Cited by 15
Endocrine disruptors and polycystic ovary syndrome: a focus on Bisphenol A and its potential pathophysiological aspects
Palioura, E., Kandaraki, E., & Diamanti‐Kandarakis, E. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0003 · Cited by 17
The polycystic ovary syndrome: what does insulin resistance have to do with it?
Ben‐Shlomo, I. (2003) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)62053-6 · Cited by 15
Polycystic Ovarian Syndrome: the Next Cardiovascular Dilemma in Women?
Srikanthan, P., Korenman, S. G., & Davis, S. S. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.05.001 · Cited by 14
The Search for the Causes of Common Hyperandrogenism, 1965 to Circa 2015
Rosenfield, R. L. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae007 · Cited by 16
Self-citation
Structure of aldehyde reductase in ternary complex with coenzyme and the potent 20α-hydroxysteroid dehydrogenase inhibitor 3,5-dichlorosalicylic acid: Implications for inhibitor binding and selectivity
Carbone, V., Chung, R. P. ‐., Endo, S., Hara, A., & El-Kabbani, O. A. L. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.08.014 · Cited by 14
Laparoscopic ovarian drilling reduces testosterone and luteinizing hormone/follicle-stimulating hormone ratio and improves clinical outcome in women with polycystic ovary syndrome
Thyagaraju, C., Sinha, P., Papa, D., & Nandeesha, H. (2019) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_161_18 · Cited by 14
Comparison of a progestin-primed ovarian stimulation protocol with a flexible GnRH antagonist protocol in patients with polycystic ovary syndrome who are participating in an IVF programme: study protocol for a randomised controlled trial
Wang, N., Zhu, Q., Ma, M., Zhou, L., Tao, Y., Wang, Y., & Kuang, Y. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038153 · Cited by 14
Polycystic Ovary Syndrome and the Neuroendocrine Consequences of Androgen Excess
Silva, M. S. B., & Campbell, R. E. (2022) · Comprehensive physiology · doi:10.1002/cphy.c210025 · Cited by 22
Steroid Hormone Profiling in Hyperandrogenism and Non-hyperandrogenism Women with Polycystic Ovary Syndrome
Ge, J., Yang, N., Zhang, X., Li, M., Zhang, W., He, J. B., Zhu, H., Cheng, X., Shen, S., & Ge, W. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-00985-0 · Cited by 13
Mutations of the hexose-6-phosphate dehydrogenase gene rarely cause hyperandrogenemic polycystic ovary syndrome
Qin, K., & Rosenfield, R. L. (2010) · Steroids · doi:10.1016/j.steroids.2010.10.001 · Cited by 13
Self-citation
CYP17 T/C (rs74357) gene polymorphism contributes to polycystic ovary syndrome susceptibility: evidence from a meta-analysis
Liu, X., Xu, M., Qian, M., & Yang, L. (2021) · Endocrine Connections · doi:10.1530/ec-21-0327 · Cited by 13
Localization and altered expression of AKR1C family members in human ovarian tissues
Ji, Q., Aoyama, C., Chen, P. K., Stolz, A., & Liu, P. (2005) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2005.03.003 · Cited by 13
Non-Cytokine Protein Profile of the Mesenchymal Stem Cell Secretome That Regulates the Androgen Production Pathway
Park, H.-S., Chugh, R. M., Pergande, M. R., Cetin, E. C., Siblini, H., Esfandyari, S., Cologna, S. M., & Al-Hendy, A. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094633 · Cited by 12
Polymorphism of the pig 17beta-hydroxysteroid dehydrogenase type1 (HSD17B1) gene and its association with reproductive traits
Liu, L. Q., Li, F. E., Deng, C. Y., Zuo, B., Zheng, R., & Xiong, Y. Z. (2008) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2008.09.004 · Cited by 12
Deciphering the cis-regulatory elements of co-expressed genes in PCOS by in silico analysis
Sarkar, C., & Maitra, A. (2007) · Gene · doi:10.1016/j.gene.2007.10.026 · Cited by 13
An Investigation of Steroid Biosynthesis Pathway Genes in Women with Polycystic Ovary Syndrome
Sharma, P., Jain, M., & Halder, A. (2022) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_86_22 · Cited by 12
Expression of SET Protein in the Ovaries of Patients with Polycystic Ovary Syndrome
Xu, B., Dai, X., YuGui, C., Lingling, G., Xue, D., Gao, C., Feiyang, D., Jia-yin, L., Gao, L., Li, M., et al. (2013) · International Journal of Endocrinology · doi:10.1155/2013/367956 · Cited by 11
Chronotype and Sleep Quality Assessment of Patients with Polycystic Ovary Syndrome
Karasu, A. F. G., Şahbaz, Ç., DOĞU, Z. F. E., Takmaz, T., Öztürk, H. Ç., & Tanoğlu, F. B. (2021) · Medical Bulletin of Haseki · doi:10.4274/haseki.galenos.2021.6584 · Cited by 12
Diagnosis and Management of Polycystic Ovary Syndrome
Diamanti-Kandarakis, E., & Farid, N. R. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3 · Cited by 11
An endocrinological perspective on polycystic ovarian syndrome
Basak, S., Dixit, A. K., Dey, R. K., Puia, L., Bora, M., Yr, S. K., & Babu, G. (2025) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112524 · Cited by 11
Le syndrome des ovaires polykystiques (SOPK)
Torre, A., & Fernandez, H. (2007) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2007.04.002 · Cited by 11
Blastocysts from patients with polycystic ovaries exhibit altered transcriptome and secretome
Katz‐Jaffe, M. G., McCallie, B. R., Janesch, A. M., Filipovits, J., Schoolcraft, W. B., & Gardner, D. K. (2010) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2010.05.010 · Cited by 10
On the Intimate Relationship of Adiposity to Polycystic Ovary Syndrome
Rosenfield, R. L., & Dumesic, D. A. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf527 · Cited by 11
Self-citation
miRNA-mRNA Network in PBMCs of PCOS Women Identifies Overactivated Stress-Activated Kinases
Krishna, M. B., Johnson, B. S., Vasudevan, M., Pillai, S. M., & Laloraya, M. (2023) · Cellular Physiology and Biochemistry · doi:10.33594/000000622 · Cited by 9
Pharmacogenetics of aldo-keto reductase 1C (AKR1C) enzymes
Alshogran, O. Y. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1376648 · Cited by 9
Differences in metabonomic profiles of abdominal subcutaneous adipose tissue in women with polycystic ovary syndrome
Di, F., Gao, D., Yao, L., Zhang, R., Qiu, J., & Song, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1077604 · Cited by 9
Insulinorésistance et syndrome des ovaires polykystiques
Bernard, L., Christin‐Maître, S., Basille, C., & Chabbert‐Buffet, N. (2003) · Gynécologie Obstétrique & Fertilité · doi:10.1016/s1297-9589(03)00009-2 · Cited by 9
Polycystic ovary syndrome and immune deregulation: what do hormones want to say?
Johnson, B. S., & Laloraya, M. (2022) · Exploration of Immunology · doi:10.37349/ei.2022.00058 · Cited by 8
Androgens: they don’t just make a man out of you
Sen, A., & Hammes, S. R. (2010) · Expert Review of Obstetrics & Gynecology · doi:10.1586/eog.10.73 · Cited by 8
Genetic relationships between early menopause and the behaviour of theca interna during follicular atresia
Rodgers, R. J., & Laven, J. S. E. (2020) · Human Reproduction · doi:10.1093/humrep/deaa173 · Cited by 8
Eine interdisziplinäre Herausforderung
Segerer, S. E., Janssen, O. E., & Keck, C. (2014) · gynäkologie + geburtshilfe · doi:10.1007/s15013-013-0209-7 · Cited by 9
Polycystic Ovary Syndrome
Sood, M., Zweig, S. B., Tolentino, M. C., Strizhevsky, M., & Poretsky, L. (2015) · Springer eBooks · doi:10.1007/978-3-319-20797-1_33-1 · Cited by 8
Defects in Ovarian Steroid Hormone Biosynthesis
Strauss, J. F., Modi, B. P., & McAllister, J. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-408134-5.00018-4 · Cited by 10
Self-citation
Transcutaneous electrical acupoint stimulation alleviates the hyperandrogenism of polycystic ovarian syndrome rats by regulating the expression of P450arom and CTGF in the ovaries.
Qu, F., Liang, Y., Zhou, J., Ma, R., Zhou, J., Wang, F., Wu, Y. T., & Fang, J. (2015) · Europe PMC (PubMed Central) · Cited by 8
Molecular cloning of equine 17β-hydroxysteroid dehydrogenase type 1 and its downregulation during follicular luteinization in vivo
Brown, K. A., Sayasith, K., Bouchard, N., Lussier, J. G., & Sirois, J. (2007) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.02097 · Cited by 8
Understanding the Secular Decline in Testosterone: Mechanisms, Consequences, and Clinical Perspectives
Fraile‐Μartinez, O., Ortega, M. A., & Montero, C. G. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020692 · Cited by 12
Accounting for the Follicle Population in the Polycystic Ovary
Dumesic, D. A., & Abbott, D. H. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_2 · Cited by 7
The Synthesis and Metabolism of Steroid Hormones
Strauss, J. F. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00004-4 · Cited by 7
Self-citation
Expression of Key Androgen-Activating Enzymes in Ovarian Steroid Cell Tumor, Not Otherwise Specified
Scheker, E. V., Kathuria, A., Esnakula, A. K., Sasano, H., Yamazaki, Y., Tevosian, S. G., Auchus, R. J., Ghayee, H. K., & Dhir, G. (2020) · Journal of Investigative Medicine High Impact Case Reports · doi:10.1177/2324709620933416 · Cited by 8
PCOS from Lifestyle to the Use of Inositol and Insulin Sensitizers
Genazzani, A. D., Prati, A., Despini, G., Marini, G. M. F., & Ricchieri, F. (2014) · ISGE series · doi:10.1007/978-3-319-03494-2_7 · Cited by 7
Study of effect of myoinositol on menstrual irregularities and skin problems in polycystic ovarian syndrome cases
Ranwa, M., Nagaria, T., Jaiswal, J., & Arya, A. K. (2017) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20172120 · Cited by 7
Syndrome des ovaires polymicrokystiques
Robin, G., Proust-Richard, C., Jonard-Catteau, S., & Dewailly, D. (2007) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(07)35089-0 · Cited by 6
Differential activity of the corticosteroidogenic enzymes in normal cycling women and women with polycystic ovary syndrome
Yamamoto, M. M. W., & de Medeiros, S. F. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09482-3 · Cited by 7
Das polyzystische Ovarsyndrom
Heutling, D., Schulz, H., Randeva, H. S., Dodt, C., & Lehnert, H. (2007) · Der Internist · doi:10.1007/s00108-006-1776-7 · Cited by 7
Le syndrome des ovaires polymicrokystiques – ou les follicules dans tous leurs excès
Robin, G., Catteau-Jonard, S., Dewailly, D., & Decanter, C. (2010) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2010.04.006 · Cited by 6
Concentrations of sex steroids in fluid from human antral follicles are dynamic and characterize transition from follicular recruitment to dominance
Johannsen, M. L., Mamsen, L. S., Zheng, M., Styrishave, B., Hay‐Schmidt, A., & Andersen, C. Y. (2025) · Fertility and Sterility · doi:10.1016/j.fertnstert.2025.08.004 · Cited by 5
Unraveling the Connection between PCOS and renal Complications: Current insights and Future Directions
Peng, H., Ren, J., Zhao, Y., Fang, X., Wang, X., Liu, C., & Wan, Z. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112235 · Cited by 7
Effects of metformin on the adrenal cortex of androgenized rats
Macedo, L. A., Carbonel, A. A. F., Simões, R. S., Fuchs, L. F. P., do Amaral, V. C., Simoncini, T., Simões, M. J. S., Baracat, E. C., & Soares, J. M. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1019342 · Cited by 5
Insulin Receptor and its Relationship with Different Forms of Insulin Resistance
Rojek, A., & Niedziela, M. (2010) · Postepy Biologii Komorki · doi:10.2478/v10052-010-0004-8 · Cited by 7
The effect of 12 weeks aerobic exercise on DHEAso4, 17OH-Progestron concentrations, number of follicles and menstrual condition of women with PCOS
Gaeini, A. A., Satarifard, S., Mohamadi, F., & Choobineh, S. (2014) · Bimonthly Journal of Hormozgan University of Medical Sciences · Cited by 5
Locus coeruleus lesions and PCOS: role of the central and peripheral sympathetic nervous system in the ovarian function of rat.
Zangeneh, F. Z., Abdollahi, A., Aminee, F., & Naghizadeh, M. M. (2012) · PubMed Central · Cited by 5
Polycystic Ovary Syndrome
Zweig, S. B., Tolentino, M. C., Strizhevsky, M., & Poretsky, L. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_33 · Cited by 5
The effect of the combination of myoinositol and D-chiroinositol in a ratio of 5:1 on the psychoemotional state and manifestations of androgen-dependent dermopathy in patients with polycystic ovary syndrome
Юрьевна, П. В., Сергеевна, А. О., & Sosna, N. A. (2021) · Russian Journal of Human Reproduction · doi:10.17116/repro20212704197 · Cited by 4
Adipositas – polyzystisches Ovarialsyndrom – Krebs
Weiss, J., & Küpker, W. (2017) · Gynäkologische Endokrinologie · doi:10.1007/s10304-017-0133-3 · Cited by 5
Natural Approaches for Treating Polycystic Ovary Syndrome
Meletis, C. D., & Zabriskie, N. (2006) · Alternative and Complementary Therapies · doi:10.1089/act.2006.12.157 · Cited by 4
Pathophysiology of Ovarian Function in the Human Female
Franks, S., Hardy, K., & Conway, G. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397175-3.00029-6 · Cited by 6
The importance of ovary-immune interactions in the context of age and disease
Zardeneta, M. E., Pickle, K. A., & Sohrabji, F. (2026) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2026.101234 · Cited by 3
GC-MS analysis and in silico docking of constituents of Cinnamomum malabatrum against CYP450 17α and CYP450 19 (Aromatase)- Key targets for hyperandrogenism
Soumya, V., Deepa, S., Thachil, K. K., Saravanan, J., & Hariprasad, R. (2023) · Drug Research · doi:10.1055/a-2142-5774 · Cited by 3
Effect of small interfering RNAs of cytochrome P450 17α‐hydroxylase/17,20‐lyase (CYP17) on androgen biosynthesis in theca cells
Du, J., Liang, X., Zeng, H., Shu, Y., Yao, S., Zhu, B., & Zhuang, G. (2008) · Cell Biology International · doi:10.1016/j.cellbi.2007.12.011 · Cited by 3
The Genetics of Polycystic Ovary Syndrome: From Genome-Wide Association to Molecular Mechanisms
Strauss, J. F., Modi, B. P., & McAllister, J. M. (2018) · Reproductive medicine for clinicians · doi:10.1007/978-3-319-78009-2_3 · Cited by 3
Self-citation
The Comparison of the Effects of Voluntary Running Wheel and Endurance Training on Il-6 and Testosterone Levels in the Rats With PCOS
Moradi, F., & Akbarnejad, A. (2021) · مجله دانشگاه علوم پزشکی اراک · doi:10.32598/jams.24.3.6212.1 · Cited by 3
Endocrine-disrupting chemicals in polycystic ovary syndrome: an evidence-based minireview
Georgescu, C. E., Şuteu, M., & Georgescu, B. (2012) · Cited by 3
Chronic Fructose Consumption May be used as a Model of Polycystic Ovary Syndrome in Pregnant Female Sprague-Dawley Rats
Arikawe, A., Iranloye, B. O., Ogunsola, A., & Daramola, A. O. (2012) · African Journal of Biomedical Research · Cited by 3
Etiología del síndrome del ovario poliquístico
Escobar-Morreale, H. F. (2006) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(06)71165-2 · Cited by 3
PCOS and metformin: from pharmacology to clinical use for women's health
Genazzani, A. D., Ricchieri, F., Prati, A., Chierchia, E., Rattighieri, E., Bosco, G., Despini, G., Campedelli, A., Farinetti, A., & Santagni, S. (2012) · IRIS UNIMORE (University of Modena and Reggio Emilia) · Cited by 3
Le syndrome des ovaires polymicrokystiques
Robin, G., Catteau-Jonard, S., Proust-Richard, C., Decanter, C., & Dewailly, D. (2012) · Elsevier eBooks · doi:10.1016/b978-2-294-70154-2.00013-3 · Cited by 4
Qualité ovocytaire et embryonnaire chez les femmes avec syndrome des ovaires polykystiques : état de l’art
Fournier, A., Torre, A., Delaroche, L., Gala, A., Mullet, T., Ferrières, A., & Hamamah, S. (2017) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2017.06.015 · Cited by 3
Clinical, ultrasonographic, and biochemical correlates of polycystic ovarian syndrome: A case–control study from a Tertiary Care Center in North India
Raina, S., Gupta, V., Sharma, S., & Bedi, G. (2018) · Journal of the Scientific Society · doi:10.4103/jss.jss_41_17 · Cited by 3
A prospective randomised controlled study on the effects of myoinositol on ovarian functions and metabolic factors in women with polycystic ovarian syndrome
Singh, P., Biswal, S., & Verma, S. K. (2020) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20205220 · Cited by 2
A review of hyperandrogenism state in polycystic ovarian syndrome
Mohamed Shabi, M., Nivya, P. S., Devika, C., Reddy, M. S., Poornima, N., R., R. K., Joseph, J., & Kolageri, S. (2023) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20233666 · Cited by 2
Effect of hydroalcoholic extract of Melia azedarach L. seeds on serum concentration of sex hormones in polycystic ovary syndrome induced in female wistar rats
Azarnia, M., Kamyab, S. Z., Mirabolghasemi, G., & Saeidnia, S. (2015) · KAUMS Journal · Cited by 2
Role of Statins in PCOS Management
Ortega, I., & Dulęba, A. J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_11 · Cited by 2
Menstrual Disorders and Hyperandrogenism in Adolescence
DiVall, S. A., & Rosenfield, R. L. (2013) · Humana Press eBooks · doi:10.1007/978-1-60761-395-4_25 · Cited by 2
Self-citation
Hyperandrogenämie - Diagnostik und Therapiekonzepte
Keck, C., & Segerer, S. E. (2016) · Springer eBooks · doi:10.1007/978-3-662-49480-6_18 · Cited by 2
Validation of the obese Ossabaw miniature pig as a model of the obese polycystic ovary syndrome phenotype with concomitant metabolic syndrome: Exploration of polycystic ovary syndrome pathophysiology using in vivo and in vitro models
Newell-Fugate, A. E. (2012) · Cited by 2
Bariatric Surgery and Reversal of Metabolic Disorders
Manco, M. (2012) · CRC Press eBooks · doi:10.1201/b12261-71 · Cited by 2
Das polyzystische Ovarsyndrom: Prototyp eines kardiometabolischen Syndroms
Heutling, D., Schulz, H., Randeva, H. S., Dodt, C., & Lehnert, H. (2007) · Der Internist · Cited by 2
Fetal Origins of Polycystic Ovary Syndrome
Abbott, D. H., Bruns, C. M., Barnett, D. K., Tarantal, A. F., Hoffmann, S. M., Zhou, R., Levine, J. E., & Dumesic, D. A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_6 · Cited by 2
GENETICS OF POLYCYSTIC OVARY SYNDROME
Sindroma, G., Jajnika, P. N., Gerak, K., & Ferk, P. (2008) · University of Zagreb University Computing Centre (SRCE) · Cited by 3
Menstrual Disorders and Hyperandrogenism in Adolescence
DiVall, S. A., & Rosenfield, R. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-73782-9_28 · Cited by 2
Self-citation
Hyperandrogenämie – Diagnostik und Therapiekonzepte
Keck, C., & Segerer, S. E. (2015) · Der Gynäkologe · doi:10.1007/s00129-015-3807-8 · Cited by 2
Polycystic ovary syndrome: a focus on anti-Müllerian hormone levels
Sir‐Petermann, T., & King, N. C. (2007) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2.6.751 · Cited by 2
Hirsutism, Acne, and Hair Loss: Management of Hyperandrogenic Cutaneous Manifestations of Polycystic Ovary Syndrome
Yaşa, C., Dural, Ö., Baştu, E., & Uğurlucan, F. G. (2016) · Gynecology Obstetrics and Reproductive Medicine · doi:10.21613/gorm.2016.613 · Cited by 2

Authors: Nelson, V. L., Qin, K.-N., Rosenfield, R. L., Wood, J. R., Penning, T. M., Legro, R. S., Strauss, J. F., & McAllister, J. M.
Affiliations: Departments of Cellular and Molecular Physiology (V.L.N., J.M.M.), Hershey, Pennsylvania 17033
Departments of Pediatrics and Medicine, University of Chicago (K.Q., R.L.R.), Chicago, Illinois 60637
Pennsylvania State University (US)
University of Pennsylvania (US)
ORCID: Rosenfield, Robert L.
Wood, Jennifer R.
Penning, Trevor M.
Legro, Richard S.
Strauss, Jerome F.
McAllister, Jan M.
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 2001-12-01
Volume: 86
Issue: 12
Pages: 5925-5933
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jcem.86.12.8088
OpenAlex: W2062389660
Cited by: 405
References: 42
Citations by year: 2026: 12 · 2025: 10 · 2024: 8 · 2023: 8 · 2022: 16 · 2021: 33 · 2020: 13 · 2019: 17 · 2018: 16 · 2017: 14 · 2016: 13 · 2015: 15 · 2014: 23 · 2013: 20 · 2012: 24
FWCI: 9.65
Type: journal article
Language: en
Open access: closed
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases (DK-47015, R01DK047015)
National Center for Research Resources (RR-00055)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD-34449, R01HD033852, HD 33852, HD-39267, HD 07305, U54HD034449, R01HD039267, HD-0118)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
Keywords: polycystic ovary syndrome, theca cells, testosterone production, 17β-hydroxysteroid dehydrogenase, AKR1C3, AKR1C1, 3β-hydroxysteroid dehydrogenase, steroidogenesis, androgen production, granulosa cells, enzyme activity
MeSH terms: Adult, Cells, Cultured, Female, Granulosa Cells, Humans, Hydroxysteroid Dehydrogenases, Isoenzymes, Ovary, Polycystic Ovary Syndrome, Reference Values, RNA, Messenger, Testosterone, Theca Cells, 20-Hydroxysteroid Dehydrogenases, 3-Hydroxysteroid Dehydrogenases, Reverse Transcriptase Polymerase Chain Reaction, 20-alpha-Hydroxysteroid Dehydrogenase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Biochemical Basis for Increased Testosterone Production in Theca Cells Propagated from Patients with Polycystic Ovary Syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks